Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 6—June 2004
Dispatch

Antibacterial Resistance, Wayampis Amerindians, French Guyana

Karine Grenet*, Didier Guillemot†, Vincent Jarlier‡, Brigitte Moreau§, Stéphane Dubourdieu*, Laurent Boyer*, Laurence Armand-Lefevre*, Pierre Bau*, and Antoine Andremont*Comments to Author 
Author affiliations: *Assistance Publique-Hôpitaux de Paris, Paris, France; †Pharmaco-Épidémiologie Institut Pasteur, Paris, France; ‡Groupe Hospitalier Pitié-Salpêtrière, Paris, France; §Centre Hospitalier de Cayenne, French Guyana

Main Article

Table 1

Antibacterial exposure in 388 Wayampi American Indians from three villages in southern French Guyana during the year preceding the studya

Antibacterial agents Frequency of antibacterial exposure in (%)
TS
(n = 85) YP
(n = 55) Z
(n = 248) Total
(n = 388) p valueb
Aminopenicillins
5.9
14.6
23.8
18.6
0.007
Metronidazole
16.5
30.9
32.3
28.6
0.15
Macrolides
8.2
1.8
11.3
9.3
0.2
Other
5.8
7.3
8.9
8.0
0.7
Overall 36.5 54.6 76.2 64.4 0.007

aFrequency of antibacterial exposure was calculated by dividing the number of all antibacterial courses during the year preceding the study by the number of persons in each village.
bAnalysis of variance (ANOVA).

Main Article

Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external